Leucine-rich repeat-containing protein 66 (LRRC66)

Leucine-rich repeat-containing protein 66 (LRRC66) is a protein encoded by the LRRC66 gene in humans[11][10]. It belongs to the leucine-rich repeat family of proteins, which participate in diverse biological processes, including cell differentiation, RNA and protein metabolic processes, and cellular organization[10][1][8][9]. LRRC66 contains typical leucine-rich repeat domains as well as immunoglobulin-like domains[1][5]. There is evidence of its expression in a variety of tissues, and it has been profiled in the context of cancer research, but there is no established link to specific therapeutic targeting, drug interactions, or direct mechanisms of disease[3][7]. There is no evidence in the current databases indicating that LRRC66 functions as a receptor, drug target, enzyme, or transporter, nor is there information on ligand-binding, drugs, clinical biomarkers, or safety concerns specific to this molecule[3][10][11]. **Key notes:** - LRRC66 is primarily classified as a structural or scaffold protein without a proven "therapeutic target" status. - Its presence in cancer tissue expression datasets does not imply a functional role as a cancer driver or biomarker at this time[3][7]. - No misspellings or anecdotal errors were found in the nomenclature. - No reported drugs, safety concerns, or mechanisms of action.

Other names

Liver regeneration-related proteinLRRC66leucine rich repeat containing 66